Literature DB >> 13782756

Mode of action and side-effects of phenformin hydrochloride.

R S WALKER, A L LINTON, W S THOMSON.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/pharmacology

Mesh：

Substances：

Year:  1960        PMID： 13782756      PMCID： PMC2098383          DOI： 10.1136/bmj.2.5212.1567

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  12 in total

1.  Phenethyldiguanide: a dangerous side-effect.

Authors:  R S WALKER; A L LINTON
Journal:  Br Med J       Date:  1959-11-14

2.  Clinical evaluation of formamidinyliminourea, a new biguanide oral blood sugar lowering compound: comparison with other hypoglycemic agents.

Authors:  L P KRALL; R F BRADLEY
Journal:  Ann Intern Med       Date:  1959-03       Impact factor: 25.391

3.  A new oral hypoglycemic drug.

Authors:  J POMERANZE
Journal:  N Y State J Med       Date:  1958-12-01

4.  Phenethyl-, amyl-, and isoamylbiguanide in the treatment of diabetes mellitus.

Authors:  W D ODELL; D C TANNER; D F STEINER; R H WILLIAMS
Journal:  AMA Arch Intern Med       Date:  1958-10

5.  Clinical report of a new hypoglycemic agent.

Authors:  J POMERANZE; H FUJIY; G T MOURATOFF
Journal:  Proc Soc Exp Biol Med       Date:  1957-05

6.  Studies related to the hypoglycemic action of phenethyldiguanide.

Authors:  R H WILLIAMS; J M TYBERGHEIN; P M HYDE; R L NIELSEN
Journal:  Metabolism       Date:  1957-07       Impact factor: 8.694

7.  Metabolic effects of phenethyldiguanide, a new hypoglycemic compound.

Authors:  J M TYBERGHEIN; R H WILLIAMS
Journal:  Proc Soc Exp Biol Med       Date:  1957-10

8.  A site of action of phenethylbiguanide, a hypoglycemic compound.

Authors:  A N WICK; E R LARSON; G S SERIF
Journal:  J Biol Chem       Date:  1958-08       Impact factor: 5.157

9.  Hypoglycemic actions of phenethylamyl-, and isoamyl-diguanide.

Authors:  R H WILLIAMS; D C TANNER; W D ODELL
Journal:  Diabetes       Date:  1958 Mar-Apr       Impact factor: 9.461

10.  Extractable insulin of the pancreas and effectiveness of oral hypoglycaemic sulfonylureas in the treatment of diabetes in man; a comparison.

Authors:  G A WRENSHALL; C H BEST
Journal:  Can Med Assoc J       Date:  1956-06-15       Impact factor: 8.262
View more
  10 in total

1.  LACTIC ACIDOSIS AND PHENFORMIN INTOXICATION. REPORT OF TWO CASES WITH REVIEW OF LITERATURE.

Authors:  J M YOUNG; L P ARMANINO
Journal:  Calif Med       Date:  1965-09

2.  Fatal lactic acidosis after an overdose of phenformin.

Authors:  D W Proctor; J M Stowers
Journal:  Br Med J       Date:  1967-10-28

3.  The management of acid-base balance in children with diabetic acidosis.

Authors:  J A Kuzemko; D W Fielding; F P Hudson
Journal:  Postgrad Med J       Date:  1969-01       Impact factor: 2.401

4.  The effect of short-term administration of antidiabetic biguanide derivatives on the blood lactate levels in healthy subjects.

Authors:  A Czyzyk; B Lao; W Bartosiewicz; Z Szczepanik; K Orlowska
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

5.  Acute pulmonary hypertension in idiopathic lactic acidosis.

Authors:  B J Sproule; E A Phillipson; C M Couves; R T Brownlee
Journal:  Can Med Assoc J       Date:  1966-01-15       Impact factor: 8.262

6.  Can phenformin-induced lactic acidosis be prevented?

Authors:  E A Gale; R B Tattersall
Journal:  Br Med J       Date:  1976-10-23

7.  Hyperlactataemia in phenformin-treated diabetics.

Authors:  S K Varma; S J Heaney; W G Whyte; R S Walker
Journal:  Br Med J       Date:  1972-01-22

8.  Lactic acidosis in diabetes.

Authors:  P J Watkins; J S Smith; M G Fitzgerald; J M Malins
Journal:  Br Med J       Date:  1969-03-22

9.  Influence of phenformin and metformin on exercise induced lactataemia in patients with diabetes mellitus.

Authors:  P Björntorp; S Carlström; S E Fagerberg; L S Hermann; A G Holm; B Scherstén; J Ostman
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

10.  Circulatory defects during phenformin lactic acidosis.

Authors:  M A Latif; M H Weil
Journal:  Intensive Care Med       Date:  1979-09       Impact factor: 17.440
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.